SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anthem, Inc. – ‘10-Q’ for 3/31/18 – ‘EX-10.2(D)’

On:  Wednesday, 4/25/18, at 12:36pm ET   ·   For:  3/31/18   ·   Accession #:  1156039-18-5   ·   File #:  1-16751

Previous ‘10-Q’:  ‘10-Q’ on 10/25/17 for 9/30/17   ·   Next:  ‘10-Q’ on 7/25/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 4/18/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/25/18  Anthem, Inc.                      10-Q        3/31/18   98:12M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    804K 
 2: EX-10.2(D)  Material Contract                                   HTML     58K 
 3: EX-10.2(E)  Material Contract                                   HTML     63K 
 4: EX-10.2(F)  Material Contract                                   HTML     72K 
 5: EX-10.2(G)  Material Contract                                   HTML     60K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
16: R1          Document And Entity Information                     HTML     50K 
17: R2          Consolidated Balance Sheets                         HTML    158K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     52K 
19: R4          Consolidated Statements Of Income                   HTML    101K 
20: R5          Consolidated Statements of Comprehensive Income     HTML     54K 
21: R6          Consolidated Statements Of Cash Flows               HTML    156K 
22: R7          Consolidated Statements Of Shareholders' Equity     HTML     75K 
23: R8          Organization                                        HTML     36K 
24: R9          Basis Of Presentation and Significant Accounting    HTML     58K 
                Policies                                                         
25: R10         Business Acquisitions                               HTML     39K 
26: R11         Investments                                         HTML    247K 
27: R12         Derivative Financial Instruments Derivative         HTML    207K 
                Financial Instruments                                            
28: R13         Fair Value                                          HTML    334K 
29: R14         Income Taxes                                        HTML     33K 
30: R15         Retirement Benefits                                 HTML     60K 
31: R16         Medical Claims Payable                              HTML    111K 
32: R17         Debt                                                HTML     53K 
33: R18         Commitments And Contingencies                       HTML     68K 
34: R19         Capital Stock                                       HTML    107K 
35: R20         Accumulated Other Comprehensive Income              HTML     91K 
36: R21         Earnings Per Share                                  HTML     41K 
37: R22         Segment Information                                 HTML     96K 
38: R23         Basis of Presentation and Significant Accounting    HTML     68K 
                Policies (Policies)                                              
39: R24         Investments (Tables)                                HTML    251K 
40: R25         Derivative Financial Instruments (Tables)           HTML    218K 
41: R26         Fair Value (Tables)                                 HTML    319K 
42: R27         Retirement Benefits (Tables)                        HTML     59K 
43: R28         Medical Claims Payable (Tables)                     HTML    113K 
44: R29         Debt (Tables)                                       HTML     36K 
45: R30         Capital Stock (Tables)                              HTML    114K 
46: R31         Accumulated Other Comprehensive Income (Tables)     HTML     93K 
47: R32         Earnings Per Share (Tables)                         HTML     38K 
48: R33         Segment Information (Tables)                        HTML    104K 
49: R34         Organization (Details)                              HTML     36K 
50: R35         Basis of Presentation and Signficant Accounting     HTML     45K 
                Policies Basis of Presentation and Significant                   
                Acconting Policies (Details)                                     
51: R36         Business Acquisitions Business Acquisition (Assets  HTML     66K 
                Liabilities Acquired) (Details)                                  
52: R37         Investments (Current And Long-Term Fixed Maturity   HTML     82K 
                Securities, Available-For-Sale) (Details)                        
53: R38         Investments (Aggregate Fair Value And Gross         HTML     77K 
                Unrealized Loss Of Fixed Maturity Securities And                 
                Equity Securities In An Unrealized Loss Position)                
                (Details)                                                        
54: R39         Investments (Amortized Cost And Fair Value Of       HTML     67K 
                Fixed Maturity Securities, By Contractual                        
                Maturity) (Details)                                              
55: R40         Investments (Proceeds and Realized Gains Losses     HTML     36K 
                From Debt Securities) (Details)                                  
56: R41         Investments (Current and Long-term Equity           HTML     46K 
                Securities) (Details)                                            
57: R42         Investments (Gains and Losses Recognized on Equity  HTML     37K 
                Securities) (Details)                                            
58: R43         Investments (Securities Lending Programs)           HTML     45K 
                (Details)                                                        
59: R44         Investments (Narrative) (Details)                   HTML     46K 
60: R45         Derivative Financial Instruments (Notional          HTML     75K 
                Amounts, Balance Sheet Location And Estimated Fair               
                Values Of Derivative Financial Instruments)                      
                (Details)                                                        
61: R46         Derivative Financial Instruments (Summary Of        HTML     61K 
                Outstanding Fair Value Hedges) (Details)                         
62: R47         Derivative Financial Instruments Derivative         HTML     37K 
                Financial Instruments (Fair Value Hedges,                        
                Financial Position) (Details)                                    
63: R48         Derivative Financial Instruments (Effect Of Cash    HTML     40K 
                Flow Hedges On Financial Statements) (Details)                   
64: R49         Derivative Financial Instruments (Income Statement  HTML     51K 
                Relationship of Fair Value and Cash Flow Hedging)                
                (Details)                                                        
65: R50         Derivative Financial Instruments (Effect Of         HTML     40K 
                Non-Hedging Derivatives On Income Statement And                  
                Included In Net Realized Gains (Losses) On                       
                Financial Instruments) (Details)                                 
66: R51         Derivative Financial Instruments (Financial         HTML     52K 
                Statement Narrative) (Details)                                   
67: R52         Fair Value (Fair Value Measurements By Level For    HTML    155K 
                Assets Measured At Fair Value On A Recurring                     
                Basis) (Details)                                                 
68: R53         Fair Value (Reconciliation Of The Beginning And     HTML     76K 
                Ending Balances Of Assets Measured At Fair Value                 
                On A Recurring Basis Using Level III Inputs)                     
                (Details)                                                        
69: R54         Fair Value (Carrying And Estimated Fair Values by   HTML     61K 
                Level Of Financial Instruments Not Recorded At                   
                Fair Value On Consolidated Balance Sheet)                        
                (Details)                                                        
70: R55         Income Taxes (Narrative) (Details)                  HTML     37K 
71: R56         Retirement Benefits (Components Of Net Periodic     HTML     51K 
                (Benefit Credit) Benefit Cost) (Details)                         
72: R57         Medical Claims Payable (Reconciliation Of The       HTML     70K 
                Beginning And Ending Balances For Medical Claims                 
                Payable By Segment) (Details)                                    
73: R58         Medical Claims Payable (Reconciliation Of Net       HTML     41K 
                Incurred Medical Claims To Benefit Expense)                      
                (Details)                                                        
74: R59         Medical Claims Payable (Narrative) (Details)        HTML     47K 
75: R60         Debt (Carrying Value Of Long-term Debt) (Details)   HTML     34K 
76: R61         Debt (Convertible Debenture Details) (Details)      HTML     45K 
77: R62         Debt (Narrative) (Details)                          HTML    113K 
78: R63         Commitments And Contingencies (Details)             HTML     56K 
79: R64         Capital Stock (Summary of Cash Dividend Activity)   HTML     40K 
                (Details)                                                        
80: R65         Capital Stock (Summary of Share Repurchases)        HTML     43K 
                (Details)                                                        
81: R66         Capital Stock (Summary of Stock Option Activity)    HTML     67K 
                (Details)                                                        
82: R67         Capital Stock (Nonvested Restricted Stock Activity  HTML     55K 
                Including Restricted Stock Units) (Details)                      
83: R68         Capital Stock (Fair Values of Options Granted       HTML     39K 
                During The Period Estimated Using Weighted-Average               
                Assumptions) (Details)                                           
84: R69         Capital Stock (Schedule Of Weighted-Average Fair    HTML     34K 
                Values Determined For The Periods) (Details)                     
85: R70         Capital Stock (Narrative) (Details)                 HTML     74K 
86: R71         Accumulated Other Comprehensive Loss                HTML     90K 
                (Reconciliation Of The Components Of Accumulated                 
                Other Comprehensive Income) (Details)                            
87: R72         Accumulated Other Comprehensive Income (Other       HTML     53K 
                Comprehensive Income (Loss) Reclassification                     
                Adjustments) (Details)                                           
88: R73         Accumulated Other Comprehensive Income (Loss)       HTML     49K 
                Accumulated Other Comprehensive Income                           
                Reclassification Adjustments (Details)                           
89: R74         Earnings Per Share (Denominator For Basic And       HTML     37K 
                Diluted Earnings Per Share) (Details)                            
90: R75         Earnings Per Share (Narrative) (Details)            HTML     36K 
91: R76         Segment Information (Financial Data By Reportable   HTML     41K 
                Segment) (Details)                                               
92: R77         Segment Information Segment Information (Major      HTML     49K 
                Product Revenues for Each Reportable Segment)                    
                (Details)                                                        
93: R78         Segment Information (Reconciliation Of Reportable   HTML     41K 
                Segments Operating Revenues To Total Revenues                    
                Reported In The Consolidated Statements Of Income)               
                (Details)                                                        
94: R79         Segment Information (Reconciliation Of Reportable   HTML     50K 
                Segments Operating Gain To Income Before Income                  
                Tax Expense Included In The Consolidated                         
                Statements Of Income) (Details)                                  
95: R80         Segment Information Segment Information             HTML     30K 
                (Narrative) (Details)                                            
97: XML         IDEA XML File -- Filing Summary                      XML    185K 
96: EXCEL       IDEA Workbook of Financial Reports                  XLSX    121K 
10: EX-101.INS  XBRL Instance -- antm-20180331                       XML   4.20M 
12: EX-101.CAL  XBRL Calculations -- antm-20180331_cal               XML    304K 
13: EX-101.DEF  XBRL Definitions -- antm-20180331_def                XML   1.02M 
14: EX-101.LAB  XBRL Labels -- antm-20180331_lab                     XML   2.36M 
15: EX-101.PRE  XBRL Presentations -- antm-20180331_pre              XML   1.47M 
11: EX-101.SCH  XBRL Schema -- antm-20180331                         XSD    234K 
98: ZIP         XBRL Zipped Folder -- 0001156039-18-000005-xbrl      Zip    359K

‘EX-10.2(D)’   —   Material Contract

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

 <!   C:   C: 
  Exhibit  
Exhibit 10.2(d)

Schedule A
Notice of Option Grant
Participant:        [●]
Company:        Anthem, Inc.
Notice:
You have been granted the following nonqualified stock option to purchase shares of common stock of the Company in accordance with the terms of the Plan and the attached Nonqualified Stock Option Award Agreement.
Plan:    2017 Anthem Incentive Compensation Plan
Grant:            Grant Date:  [●]
            Option Price per Share: $[●]
            Number of Shares under Option:  [●]

Exercisability:
Subject to the terms of the Plan and this Agreement, your Option will become exercisable on and after the dates indicated below as to the number of Shares set forth below opposite each such date, plus any Shares as to which your Option could have been exercised previously but was not so exercised.

Shares
Date
 
 
 
 
 
 
 
 
 
 
 
 

In the event that a Change of Control (as defined in the Plan) occurs before your Termination, your Option will remain subject to the terms of this Agreement, unless the successor company does not assume your Option. If a successor company does not assume your Option, then your Option shall become fully exercisable immediately prior to the Change of Control.
Expiration Date:
Your Option will expire ten years from the Grant Date, subject to earlier termination as set forth in the Plan and this Agreement.
Acceptance:
In order to accept your Options, you must electronically accept this Agreement through the Company’s broker at any time within ninety (90) days after the Grant Date. To effect your acceptance, please follow the instructions included with your grant materials. Acceptance of the Agreement includes acceptance of the terms and conditions of the Plan. If you do not timely and electronically accept this Agreement, this Agreement will be null and void as of the 90th day after the Grant Date and you will have no right or claim to the Options described above.





Exhibit 10.2(d)

Nonqualified Stock Option Award Agreement

This Nonqualified Stock Option Award Agreement (this “Agreement”) dated as of the Grant Date (the “Grant Date”) set forth in the Notice of Option Grant attached as Schedule A hereto (the “Grant Notice”) is made between Anthem, Inc. (the “Company”) and the Participant set forth in the Grant Notice. The Grant Notice is included in and made part of this Agreement.
1.    Grant of the Option. Subject to the provisions of this Agreement and the provisions of the Plan, the Company hereby grants to the Participant, pursuant to the Plan, the right and option (the “Option”) to purchase all or any part of the number of shares of common stock of the Company (“Shares”) as set forth in the Grant Notice at an Option Price (“Option Price”) per share and on the other terms as set forth in the Grant Notice. This Option is intended to be a nonqualified stock option for federal income tax purposes.

2.
Method of Exercise of the Option.

(a)    The Participant may exercise the Option, to the extent then exercisable, by delivering a notice to the Company’s captive broker in a form specified or accepted by the captive broker, specifying the number of Shares with respect to which the Option is being exercised.

(b)    At the time the Participant exercises the Option, the Participant shall pay the Option Price of the Shares as to which the Option is being exercised and applicable taxes (i) in United States dollars by personal check, bank draft or money order; (ii) subject to such terms, conditions and limitations as the Compensation Committee of the Board of Directors of the Company (“Committee”) may prescribe, by tendering (either by actual delivery or attestation) unencumbered Shares previously acquired by the Participant having an aggregate Fair Market Value at the time of exercise equal to the total Option Price of the Shares for which the Option is so exercised; (iii) subject to such terms, conditions and limitations as the Committee may prescribe, a cashless (broker-assisted) exercise that complies with all applicable laws; or (iv) by a combination of the consideration provided for in the foregoing clauses (i), (ii) and (iii).

3.    Termination. The Option shall terminate upon the Participant’s Termination for any reason and no Shares may thereafter be purchased under the Option except as provided below. Notwithstanding anything contained in this Agreement, the Option shall not be exercisable after the Expiration Date.

(a)    Retirement. If the Participant’s Termination is due to Retirement (for purposes of this Agreement, defined as the Participant’s Termination after attaining age fifty-five (55) with at least ten (10) completed years of service or after attaining age sixty-five (65)), the Option shall continue to become exercisable according to the schedule set forth in the Grant Notice; provided that the Option shall terminate on the five-year anniversary of the date of the Participant’s Retirement but not later than the Expiration Date noted on the attached Schedule A; provided, further, that if the Participant’s Termination is due to Retirement during the calendar year of the Grant Date, the Option shall be immediately terminated on a pro-rata basis, measured by the number of completed full months in that calendar year during which the Participant was employed by the Company or an Affiliate (e.g., if the Participant’s Retirement occurs in September, 33.3% (or 4/12) of the Option shall be immediately terminated), and the non-terminated portion of the Option shall continue to become exercisable according to the schedule set forth in the Grant Notice.1 
(b)    Death and Disability. If the Participant’s Termination is due to the Participant’s death or Disability (for purposes of this Agreement, as defined in the applicable Anthem Long-Term Disability Plan), the Option shall immediately become fully exercisable and shall terminate on the five-year anniversary of the date of such Termination but not later than the Expiration Date noted on the attached Schedule A.

___________________________________________________
1 This retirement provision is deleted in non-annual retention grants.



Exhibit 10.2(d)

(c)    Termination without Cause. Unless Section 3(e) is applicable, if the Participant’s Termination is by the Company or an Affiliate without Cause (for purposes of this Agreement, defined as a violation of “conduct” as such term is defined in the Anthem HR Corrective Action Policy and if the Participant participates in the Anthem, Inc. Executive Agreement Plan (the "Agreement Plan"), the Key Associate Agreement or the Key Sales Associate Agreement also as defined in that plan or agreement) or voluntarily by the Participant, the Option, to the extent exercisable as of the date of such Termination, shall thereafter only be exercisable for a period of ninety (90) days from the date of such Termination., but not later than the Expiration Date noted on the attached Schedule A.
(d)    Cause. If the Participant’s Termination is for Cause, even if on the date of such Termination the Participant has met the definition of Retirement or Disability, then the portion of the Option that has not been exercised shall immediately terminate.
(e)    Termination after Change in Control. If after a Change in Control the Participant’s Termination is (i) by the Company or an Affiliate without Cause or (ii) if the Participant participates in the Executive Agreement Plan, by the Participant for Good Reason (as defined in the Executive Agreement Plan), the Option shall immediately become fully exercisable and shall terminate on the five-year anniversary of the date of such Termination but not later than the Expiration Date noted on the attached Schedule A.
(f)    Clawback Provision. Notwithstanding any other provisions of this Agreement to the contrary, in the event that the Participant is a non-executive participant in the Agreement Plan or is an Executive (as defined by the Company) at the time of the Participant’s Termination, regardless of whether the Executive is then a participant in such Agreement Plan, the Option shall immediately terminate if the Participant breaches any provision of Section 3.6 or 3.10 of the Agreement Plan, in which case the Participant shall be subject to the “Return of Consideration” provision contained in Section 3.7 of the Agreement Plan.
4.    Transferability of the Option. The Option shall not be transferable or assignable by the Participant except as provided in this Section 4 and the Option shall be exercisable, during the Participant’s lifetime, only by him/her or, during periods of legal disability, by his guardian or other legal representative. No Option shall be subject to execution, attachment, or similar process. The Participant shall have the right to appoint any individual or legal entity in writing, on a Designation of Beneficiary form as his/her beneficiary to receive any Option (to the extent not previously terminated or forfeited) under this Agreement upon the Participant’s death. Such designation under this Agreement may be revoked by the Participant at any time and a new beneficiary may be appointed by the Participant by execution and submission to the Company, or its designee, of a revised Designation of Beneficiary form to this Agreement. In order to be effective, a designation of beneficiary must be completed by the Participant on the Designation of Beneficiary form and received by the Company, or its designee, prior to the date of the Participant’s death. If the Participant dies without such designation, the Option may be exercised only by the executor or administrator of the Participant’s estate or by a person who shall have acquired the right to such exercise by will or by the laws of descent and distribution.

5.    Taxes and Withholdings. At the time of receipt of Shares upon the exercise of all or any part of the Option, the Participant shall pay to the Company in cash (or make other arrangements, in accordance with Article XVIII of the Plan, for the satisfaction of) any taxes of any kind required by law to be withheld with respect to such Shares; provided, however, that pursuant to any procedures, and subject to any limitations as the Committee may prescribe and subject to applicable law, the Participant may elect to satisfy, in whole or in part, such withholding obligations by (a) withholding Shares otherwise deliverable to the Participant pursuant to the Option (provided, however, that the amount of any Shares so withheld shall not exceed the amount necessary to satisfy required Federal, state, local and non-United States withholding obligations using the minimum statutory withholding rates for Federal, state, local and/or non-U.S. tax purposes, including payroll taxes, that are applicable to supplemental taxable income) and/or (b) tendering to the Company Shares owned by the Participant (or the Participant and the Participant’s spouse jointly) based, in each case, on the Fair Market Value of the Shares on the payment date as determined by the Committee. Any such election made by the Participant must be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.



Exhibit 10.2(d)

6.    No Rights as a Shareholder. Neither the Participant nor any other person shall become the beneficial owner of the Shares subject to the Option, nor have any rights to dividends or other rights as a shareholder with respect to any such Shares, until the Participant has actually received such Shares following the exercise of the Option in accordance with the terms of the Plan and this Agreement.
7.    No Right to Continued Employment. Neither the Option nor any terms contained in this Agreement shall confer upon the Participant any express or implied right to be retained in the employment or service of the Company or any Affiliate for any period, nor restrict in any way the right of the Company, which right is hereby expressly reserved, to terminate the Participant’s employment or service at any time with or without Cause. The Participant acknowledges and agrees that any right to exercise the Option is earned only by continuing as an employee of the Company or an Affiliate at the will of the Company or such Affiliate, or satisfaction of any other applicable terms and conditions contained in the Plan and this Agreement, and not through the act of being hired, being granted the Option or acquiring Shares hereunder.

8.    The Plan. This Agreement is subject to all the terms, provisions and conditions of the Plan, which are incorporated herein by reference, and to such regulations as may from time to time be adopted by the Committee. Unless defined herein, capitalized terms are as defined in the Plan. In the event of any conflict between the provisions of the Plan and this Agreement, the provisions of the Plan shall control, and this Agreement shall be deemed to be modified accordingly. The Plan and the prospectus describing the Plan can be found on the Company’s HR intranet. A paper copy of the Plan and the prospectus shall be provided to the Participant upon the Participant’s written request to the Company at Anthem, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention: Corporate Secretary, Shareholder Services Department.

9.
Compliance with Laws and Regulations.
(a)    The Option and the obligation of the Company to sell and deliver Shares hereunder shall be subject in all respects to (i) all applicable Federal and state laws, rules and regulations and (ii) any registration, qualification, approvals or other requirements imposed by any government or regulatory agency or body which the Committee shall, in its discretion, determine to be necessary or applicable. Moreover, the Option may not be exercised if its exercise, or the receipt of Shares pursuant thereto, would be contrary to applicable law. If at any time the Company determines, in its discretion, that the listing, registration or qualification of Shares upon any national securities exchange or under any state or Federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable, the Company shall not be required to deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement unless and until such listing, registration, qualification, consent or approval has been effected or obtained, or otherwise provided for, free of any conditions not acceptable to the Company.
(b)    The Shares received upon the exercise of the Option shall have been registered under the Securities Act of 1933 (“Securities Act”). If the Participant is an “affiliate” of the Company, as that term is defined in Rule 144 under the Securities Act (“Rule 144”), the Participant may not sell the Shares received except in compliance with Rule 144. Certificates representing Shares issued to an “affiliate” of the Company may bear a legend setting forth such restrictions on the disposition or transfer of the Shares as the Company deems appropriate to comply with Federal and state securities laws.
(c)    If at the time of exercise of all or part of the Option, the Shares are not registered under the Securities Act, and/or there is no current prospectus in effect under the Securities Act with respect to the Shares, the Participant shall execute, prior to the delivery of any Shares to the Participant by the Company pursuant to this Agreement, an agreement (in such form as the Company may specify) in which the Participant represents and warrants that the Participant is purchasing or acquiring the shares acquired under this Agreement for the Participant's own account, for investment only and not with a view to the resale or distribution thereof, and represents and agrees that any subsequent offer for sale or distribution of any kind of such Shares shall be made only pursuant to either (i) a registration statement on an appropriate form under the Securities Act, which registration statement has become effective and is current with regard to the Shares being offered or sold, or (ii) a specific exemption from the registration requirements of the Securities Act, but in claiming such exemption the Participant shall, prior to any offer for sale of



Exhibit 10.2(d)

such Shares, obtain a prior favorable written opinion, in form and substance satisfactory to the Company, from counsel for or approved by the Company, as to the applicability of such exemption thereto.
10.    Notices. All notices by the Participant or the Participant’s assignees shall be addressed to Anthem, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention: Stock Administration, or such other address as the Company may from time to time specify. All notices to the Participant shall be addressed to the Participant at the Participant’s address in the Company's records.

11.    Other Plans. The Participant acknowledges that any income derived from the exercise of the Option shall not affect the Participant’s participation in, or benefits under, any other benefit plan or other contract or arrangement maintained by the Company or any Affiliate.

12.    Recoupment Policy for Incentive Compensation. The Company's Recoupment Policy for Incentive Compensation, as may be amended from time to time, shall apply to the Option, any Shares acquired upon exercise of the Option and any profits realized from the sale of such Shares to the extent that the Participant is covered by such policy. If the Participant is covered by such policy, the policy may apply to recoup the Option, any Shares acquired upon exercise of the Option or profits realized from the sale of Shares previously covered by the Option either before, on or after the date on which the Participant becomes subject to such policy.



ANTHEM, INC.

By:        ______________________________
Printed:    Lewis Hay III
    Its:    Chair, Compensation Committee
of the Board of Directors




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/25/188-K
For Period end:3/31/18
 List all Filings 

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/21/24  Elevance Health, Inc.             10-K       12/31/23  153:25M
 2/15/23  Elevance Health, Inc.             10-K       12/31/22  152:27M
 2/16/22  Elevance Health, Inc.             10-K       12/31/21  153:26M
 2/18/21  Elevance Health, Inc.             10-K       12/31/20  160:28M
↑Top
Filing Submission 0001156039-18-000005   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 12:46:28.1am ET